Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events
Related Experiment Video
Updated: May 14, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Rishi Puri1, Kathy Wolski, Kiyoko Uno
1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Insights
Risk factor modification therapies led to plaque regression in the left main coronary artery (LMCA), but progression occurred in epicardial segments. Patients experiencing major adverse cardiovascular events (MACE) showed progressive LMCA disease.
Area of Science:
- Cardiology
- Vascular Biology
- Atherosclerosis Research
Background:
- Limited understanding of left main coronary artery (LMCA) atherosclerosis natural history and clinical impact.
- Epicardial coronary disease progression slows with risk factor modification, but LMCA behavior is less understood.
Purpose of the Study:
- To evaluate left main coronary artery (LMCA) atherosclerosis progression in patients undergoing risk factor modifying therapies.
- To investigate the relationship between LMCA plaque burden changes, arterial remodeling, and major adverse cardiovascular events (MACE).
Main Methods:
- Serial intravascular ultrasound imaging in 340 patients across 7 clinical trials.
- Characterization of LMCA and epicardial coronary disease progression.
- Analysis of plaque burden changes, remodeling, and MACE incidence.
Main Results:
- Left main coronary artery (LMCA) plaque regression observed (-0.39% PAV), contrasting with epicardial segment progression (+0.37% PAV).
- LMCA lumen volume changes correlated with external elastic membrane and plaque volume.
- Patients with MACE had smaller baseline LMCA lumen area and greater plaque progression.
Conclusions:
- Left main coronary artery (LMCA) atherosclerosis demonstrates responsiveness to systemic risk factor modification.
- Progressive LMCA disease and constrictive remodeling are associated with increased MACE risk.
Objectives:
The aim of this study was to evaluate the progression of atherosclerosis within the left main coronary artery (LMCA) in association with risk factor modifying therapies.
Background:
Despite studies demonstrating slowing of disease progression within epicardial coronaries with risk factor modification, little is known about the natural history and clinical sequelae of atherosclerosis progression within the LMCA.
Methods:
In 340 patients with angiographic coronary artery disease who underwent serial intravascular ultrasound imaging to evaluate the effects of anti atherosclerotic therapies across 7 clinical trials, LMCA and epicardial disease progression was characterized. Relationships between changes in plaque burden with remodeling parameters and the incidence of major adverse cardiovascular events (MACE) (death, myocardial infarction, hospital stay for unstable angina, and coronary revascularization) were investigated.
Results:
Plaque regression was observed in the LMCA segment, and progression was observed in adjacent epicardial segments (percent atheroma volume [PAV] -0.39 ± 0.1% vs. +0.37 ± 0.1%, p < 0.001). Changes in LMCA lumen volume correlated strongly with changes in external elastic membrane (beta coefficient 0.91, p < 0.001) and negatively with the change in PAV (beta coefficient -0.55, p < 0.001). Patients who experienced a MACE had smaller baseline LMCA minimum lumen area (11.6 vs. 12.2 mm(2), p = 0.05) and greater progression of PAV in the LMCA (+0.51 ± 0.3% vs. -0.35 ± 0.2%, p = 0.02) compared with those who were MACE-free. Significant reductions from baseline in both external elastic membrane (-4.7 ± 1.7 mm(3), p < 0.01) and lumen volumes (-4.0 ± 1 mm(3), p < 0.01) were also observed in those having an event.
Conclusions:
Left main coronary atherosclerosis responds to systemic risk factor modification. Patients experiencing a MACE were more likely to demonstrate progressive disease and constrictive arterial remodeling within the LMCA segment.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction

